Login
BUSINESS/TECH
CLINICAL
REGULATORY
PROFILES
GRAND ROUNDS
EVENTS
Contact Us
Archives
Alzheimer’s Treatment
FDA Approves Controversial Alzheimer's Drug
Jul 12, 2021 at 03:30 pm
by
Staff
On June 7, the Food & Drug Administration approved Aduhelm (aducanumab) to treat Alzheimer's patients, making it the first new drug approval for a disease impacting more t....
Read More
RECENT NEWS
Powered by Bondware